Brainstorm Cell Therapeutics (BCLI) had the highest return between 2002 and 2004 by a US stock, returning 9,264.8%.

ASSET	YEARS	% RETURN
Brainstorm Cell Therapeutics (BCLI)	2002-2004	9,264.8%
Encore Capital (ECPG)	2002-2004	9,046.15%
Oramed Pharmaceuticals (ORMP)	2002-2004	8,275.95%
Frontline (FRO)	2002-2004	8,065.33%
NetEase (NTES)	2002-2004	6,957.38%
Cheniere Energy (LNG)	2002-2004	6,605.73%
USANA Health Sciences (USNA)	2002-2004	5,163.16%
TherapeuticsMD (TXMD)	2002-2004	4,950.01%
Inuvo (INUV)	2002-2004	3,650%
Insteel Industries (IIIN)	2002-2004	2,767.09%
Axon Enterprise (AXON)	2002-2004	2,678.51%
ArcelorMittal SA ADR (MT)	2002-2004	2,047.38%
China Yuchai International (CYD)	2002-2004	1,956.87%
Houston American Energy (HUSA)	2002-2004	1,860.12%
Companhia Siderurgica Nacional ADR (SID)	2002-2004	1,835.98%
Denison Mines (DNN)	2002-2004	1,707.39%
DSS (DSS)	2002-2004	1,486.67%
MEDIFAST (MED)	2002-2004	1,430.5%
FARO Technologies (FARO)	2002-2004	1,420.98%
Sohu (SOHU)	2002-2004	1,400.85%
Ziff Davis (ZD)	2002-2004	1,387.04%
Travelzoo (TZOO)	2002-2004	1,368.15%
Stonex (SNEX)	2002-2004	1,120.75%
Sono-Tek (SOTK)	2002-2004	1,032%
CBAK Energy Technology (CBAT)	2002-2004	1,020%